Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.
This corporate disclosure from was processed by Pulse News Wire on February 24, 2026. It represents a primary source document for Japanese M&A sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.
Source disclosure: February 24, 2026 MIZUHO MEDY CO.,LTD. [4595.T] TOKYO — Mizuho Medy Co., Ltd. announced on Friday that its board of directors has resolved to distribute a dividend based on earnings as of December 31, 2025. The decision was made during a meeting held on February 24, 2026, and will be presented for approval at the company's upcoming 49th ordinary shareholders' meeting scheduled for March 27, 2026. According to the announcement, the dividend will amount to ¥952 mill